Last edition
News about "Stelis Biopharma"
Stelis Biopharma's facility receives EIR from US FDA
The company received the EIR from USFDA for the drug-device combination to be commercialised from the company's flagship facility in Bengaluru<br />
Stelis Biopharma | 20/01/2023 | By Sudeep Soparkar | 446
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members